Literature DB >> 28927977

The role of pulmonary metastasectomy for hepatoblastoma in children with metastasis at diagnosis: Results from the JPLT-2 study.

Tomoro Hishiki1, Kenichiro Watanabe2, Kohmei Ida2, Ken Hoshino2, Tomoko Iehara2, Yuki Aoki2, Takuro Kazama2, Kentaro Kihira2, Yuichi Takama2, Tomoaki Taguchi2, Junya Fujimura2, Shohei Honda2, Kimikazu Matsumoto2, Makiko Mori2, Michihiro Yano2, Akiko Yokoi2, Yukichi Tanaka2, Hiroshi Fuji2, Osamu Miyazaki2, Kenichi Yoshimura2, Tetsuya Takimoto2, Eiso Hiyama2.   

Abstract

BACKGROUND/
PURPOSE: The purpose of this study was to clarify the role of pulmonary metastasectomy in hepatoblastomas with lung metastasis at diagnosis. We reviewed cases enrolled in the JPLT-2 study.
METHODS: A total of 360 cases with hepatoblastoma were enrolled. The clinical courses and outcome of 60 cases with pulmonary metastasis at diagnosis were reviewed, focusing on metastasectomy.
RESULTS: Induction chemotherapy resulted in eradication of nodules in 26, residual nodules in 33, and early treatment-related death in one. Of the 33 cases with residual nodules, 11 underwent complete resection of the lung lesions, and among these, progression was reported in five. Complete resection of the liver tumor was not achieved in two of these. Three underwent incomplete resection of lung nodules, eventually leading to progression. Twelve cases with incomplete or no liver tumor resection progressed regardless of the status of lung lesions. Contrarily, among patients who underwent complete resection of the liver tumor, half were cured without metastasectomy.
CONCLUSIONS: Metastasectomy for residual pulmonary nodules after induction chemotherapy is effective provided that the liver tumor could be completely resected. TYPE OF STUDY: Prospective Cohort Study. LEVEL OF EVIDENCE: Level II.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hepatoblastoma; Lung metastasis; Metastasectomy; Pulmonary metastasis; Thoracotomy

Mesh:

Year:  2017        PMID: 28927977     DOI: 10.1016/j.jpedsurg.2017.08.031

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  11 in total

1.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17

2.  MYBL2 accelerates epithelial-mesenchymal transition and hepatoblastoma metastasis via the Smad/SNAI1 pathway.

Authors:  Meng Wei; Ran Yang; Mujie Ye; Yong Zhan; Baihui Liu; Lingdu Meng; Lulu Xie; Min Du; Junfeng Wang; Runnan Gao; Deqian Chen; Rui Dong; Kuiran Dong
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

Review 3.  Fluorescence-Guided Surgery for Hepatoblastoma with Indocyanine Green.

Authors:  Yohei Yamada; Michinobu Ohno; Akihiro Fujino; Yutaka Kanamori; Rie Irie; Takako Yoshioka; Osamu Miyazaki; Hajime Uchida; Akinari Fukuda; Seisuke Sakamoto; Mureo Kasahara; Kimikazu Matsumoto; Yasushi Fuchimoto; Ken Hoshino; Tatsuo Kuroda; Tomoro Hishiki
Journal:  Cancers (Basel)       Date:  2019-08-20       Impact factor: 6.639

Review 4.  How Do Synchronous Lung Metastases Influence the Surgical Management of Children with Hepatoblastoma? An Update and Systematic Review of the Literature.

Authors:  Roberta Angelico; Chiara Grimaldi; Carlo Gazia; Maria Cristina Saffioti; Tommaso Maria Manzia; Aurora Castellano; Marco Spada
Journal:  Cancers (Basel)       Date:  2019-10-31       Impact factor: 6.639

5.  A MicroRNA Cluster in the DLK1-DIO3 Imprinted Region on Chromosome 14q32.2 Is Dysregulated in Metastatic Hepatoblastomas.

Authors:  Shohei Honda; Aniruddha Chatterjee; Anna L Leichter; Hisayuki Miyagi; Masashi Minato; Sunao Fujiyoshi; Momoko Ara; Norihiko Kitagawa; Mio Tanaka; Yukichi Tanaka; Masato Shinkai; Kanako C Hatanaka; Akinobu Taketomi; Michael R Eccles
Journal:  Front Oncol       Date:  2020-11-12       Impact factor: 6.244

Review 6.  A narrative review of the challenges and countermeasures in hepatoblastoma management during COVID-19 epidemic.

Authors:  Hang Xu; Yan Zhou; Rui Sun; Xuelai Liu; Mei Diao; Xianghai Ren; Long Li
Journal:  Transl Pediatr       Date:  2020-12

7.  CHIC Risk Stratification System for Predicting the Survival of Children With Hepatoblastoma: Data From Children With Hepatoblastoma in China.

Authors:  Junting Huang; Yang Hu; Hong Jiang; Yanjie Xu; Suying Lu; Feifei Sun; Jia Zhu; Juan Wang; Xiaofei Sun; Juncheng Liu; Zijun Zhen; Yizhuo Zhang
Journal:  Front Oncol       Date:  2020-11-18       Impact factor: 6.244

8.  Two-stage laparoscopic resection of giant hepatoblastoma in infants combined with liver partial partition and artery ligation.

Authors:  Yaohao Wu; Lexiang Zeng; Ronglin Qiu; Jie Zhang; Jianhang Su; Minyi Liao; Xiaogeng Deng
Journal:  World J Surg Oncol       Date:  2021-02-25       Impact factor: 2.754

9.  Tumor-Background Ratio is an effective method to identify tumors and false-positive nodules in indocyanine-green navigation surgery for pediatric liver cancer.

Authors:  Jun Feng; Hong Qin; Wei Yang; Haiyan Cheng; Jiatong Xu; Jianyu Han; Jianing Mou; Huanmin Wang; Xin Ni
Journal:  Front Pediatr       Date:  2022-07-27       Impact factor: 3.569

10.  Combined Use of Three-Dimensional Construction and Indocyanine Green-Fluorescent Imaging for Resection of Multiple Lung Metastases in Hepatoblastoma.

Authors:  Shugo Komatsu; Keita Terui; Mitsuyuki Nakata; Ryohei Shibata; Satoru Oita; Yunosuke Kawaguchi; Hiroko Yoshizawa; Tomoya Hirokawa; Erika Nakatani; Tomoro Hishiki
Journal:  Children (Basel)       Date:  2022-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.